The Primary Immune Deficiency Treatment Consortium (PIDTC) has launched the IMPACT study to monitor immune responses and clinical trajectories in patients with inborn errors of immunity. This initiative aims to enhance understanding and treatment of primary immune deficiencies.
impact immune monitoring and phenotype assessment of clinical trajectory for patients with inborn errors of immunity from the primary immune deficiency treatment consortium pidtc
Original title: “IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for Patients with Inborn Errors of Immunity from the Primary Immune Deficiency Treatment Consortium (PIDTC).”